B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Virology

• Publication date

  2005-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.79.6.3401-3408.2005PMID 15731234PMCID PMC1075701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China

  2004cited by this paper
• Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.

  2004cited by this paper
• Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.

  2004cited by this paper
• Caution Urged on SARS Vaccines

  2004cited by this paper
• Medicine. Caution urged on SARS vaccines.

  2004cited by this paper
• Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution.

  2004cited by this paper
• Antigenicity Analysis of Different Regions of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein

  2004cited by this paper
• A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

  2004cited by this paper
• The phylogeny of SARS coronavirus

  2004cited by this paper
• Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice

  2004cited by this paper
• Profile of Antibodies to the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Probable SARS Patients

  2004cited by this paper
• Identification of an HLA-A*0201–restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein

  2004cited by this paper
• T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS

  2004cited by this paper
• Treatment of severe acute respiratory syndrome with convalescent plasma.

  2003cited by this paper
• Coronavirus as a possible cause of severe acute respiratory syndrome

  2003cited by this paper
• Treatment of severe acute respiratory syndrome with convalescent plasma.

  2003cited by this paper
• Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus

  2003cited by this paper
• A novel coronavirus associated with severe acute respiratory syndrome.

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• A cluster of cases of severe acute respiratory syndrome in Hong Kong.

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003cited by this paper
• Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage

  2003cited by this paper
• Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• Effects of a SARS-associated coronavirus vaccine in monkeys

  2003cited by this paper
• Identification of severe acute respiratory syndrome in Canada.

  2003cited by this paper
• [Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area].

  2003cited by this paper
• Mass Spectrometric Characterization of Proteins from the SARS Virus

  2003cited by this paper
• Phylogeny of the SARS Coronavirus

  2003cited by this paper
• A major outbreak of severe acute respiratory syndrome in Hong Kong.

  2003cited by this paper
• Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

  2003cited by this paper
• How the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past

  2003cited by this paper
• Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever

  2002cited by this paper
• The relationship between the occurrence of undifferentiated bovine respiratory disease and titer changes to bovine coronavirus and bovine viral diarrhea virus in 3 Ontario feedlots.

  2001cited by this paper
• CD4 and CD8 T Cells Have Redundant But Not Identical Roles in Virus-Induced Demyelination

  2000cited by this paper
• CD4 and CD8 T Cells Have Redundant But Not Identical Roles in Virus-Induced Demyelination1

  2000cited by this paper
• CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity

  1995cited by this paper
• Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement

  1995influential reference
• Human Coronavirus Infections

  1995cited by this paper
• Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity.

  1993influential reference
• Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus

  1992influential reference
• Structure of antigens

  1992cited by this paper
• Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

  1992influential reference
• Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S.

  1990cited by this paper
• Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

  1990cited by this paper
• Antibody-dependent enhancement of viral infectivity.

  1986cited by this paper
• Pathogenesis of feline infectious peritonitis: nature and development of viremia.

  1981cited by this paper
• Immunologic phenomena in the effusive form of feline infectious peritonitis.

  1980cited by this paper

• Broad-spectrum pan-genus and pan-family virus vaccines

  2023cites this paper
• Comparison of immune response to various SARS-CoV-2 vaccines within 6 months after starting vaccination and following revaccination

  2023cites this paper
• Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

  2022cites this paper
• Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2

  2022cites this paper
• A Bioinformatics Approach to Investigate Structural and Non-Structural Proteins in Human Coronaviruses

  2022cites this paper
• Comparative Study of SARS-CoV-1, SARS-CoV-2 and MERS-CoV Protein Structure

  2022cites this paper
• Reactivity and Safety of BioNTech/Pfizer® Vaccine Anti-SARS-CoV-2, in Health Personnel from the Mexican State of Guanajuato

  2022cites this paper
• Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice

  2022cites this paper
• COVID-19 Vaccination: From Interesting Agent to the Patient

  2021cites this paper
• A measles-vectored COVID-19 vaccine induces long-term immunity and protection from SARS-CoV-2 challenge in mice

  2021cites this paper
• Determination of Spectrum of Symptoms Observed Followed by Administration of 1st and 2nd Doses of COVISHIELD™ Vaccine in Datta Meghe Institute of Medical Sciences (Deemed to be University) – A Study Protocol

  2021cites this paper
• mRNA-based COVID-19 vaccines: a new age

  2021cites this paper
• Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats

  2021cites this paper
• Misdiagnosis of SARS-CoV-2: A Critical Review of the Influence of Sampling and Clinical Detection Methods

  2021cites this paper
• the COVID-19 Pandemic : Current Status and Future Perspectives

  2021influential citation
• SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing

  2021cites this paper
• Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses

  2021cites this paper
• Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats

  2020cites this paper
• Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2

  2020cites this paper
• A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease

  2020cites this paper
• Validation of a commercially available SARS-CoV-2 serological immunoassay

  2020cites this paper
• ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens

  2020cites this paper
• Universal coronavirus vaccines: the time to start is now

  2020cites this paper
• In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein

  2020cites this paper
• Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients

  2020cites this paper
• Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma

  2020influential citation
• Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design

  2020influential citation
• Lessons for COVID-19 Immunity from Other Coronavirus Infections

  2020cites this paper
• Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine

  2020cites this paper
• Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients

  2020cites this paper
• A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

  2020cites this paper
• Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy

  2020cites this paper
• Coronavirus Proteins as Ion Channels: Current and Potential Research

  2020cites this paper
• How Useful is COVID-19 Antibody Testing – A Current Assessment for Oncologists

  2020cites this paper
• Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives

  2020cites this paper
• A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host

  2020cites this paper
• SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

  2020cites this paper
• Fluctuating High Throughput Serological Assay Results in Recurrent Convalescent Plasma Donors

  2020cites this paper
• COMPARATIVE EVALUATION OF THE ORIGIN, EVOLUTION, TRANSMISSION, DIAGNOSIS, AND VACCINE DEVELOPMENT OF THREE HIGHLY PATHOGENIC HUMAN CORONAVIRUSES (SARS-COV, MERS-COV AND SARS-COV-2)

  2020cites this paper
• Coronavirus vaccine development: from SARS and MERS to COVID-19

  2020cites this paper
• Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2

  2020cites this paper
• Genetic evolution analysis of SARS-CoV-2 ORF 1ab/S/M protein and screening of epitopes of mRNA vaccine

  2020cites this paper
• Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”

  2020cites this paper
• Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2

  2020cites this paper
• Older Human B Cells and Antibodies

  2019cites this paper
• Identification of Novel Linear Epitopes Located in the Infectious Bronchitis Virus Spike S2 Region

  2018cites this paper
• Older Human B Cells and Antibodies

  2017cites this paper
• Pulmonary immunity to viruses.

  2017cites this paper
• Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness

  2014cites this paper
• Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody

  2014cites this paper
• Evaluations Of Severe Acute Respiratory Syndrome Coronavirus Therapeutics And A Viral Capacity For Plasticity And Escape.

  2013cites this paper
• Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing

  2012cites this paper
• Development of Instantaneous Protection against SARS-CoV with Implications for Multiple RNA Viruses

  2012cites this paper
• A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge

  2011cites this paper
• Viruses and Multiple Sclerosis

  2011cites this paper
• SARS-CoV 9b Protein Diffuses into Nucleus, Undergoes Active Crm1 Mediated Nucleocytoplasmic Export and Triggers Apoptosis When Retained in the Nucleus

  2011cites this paper
• Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential

  2011cites this paper
• Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus

  2010cites this paper
• Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV

  2009cites this paper
• SARS Coronavirus Accessory Gene Expression and Function

  2009cites this paper
• The spike protein of SARS-CoV — a target for vaccine and therapeutic development

  2009cites this paper
• Development of SARS-COV therapeutics using quaternary protein mimetics

  2009cites this paper
• SARS CORONAVIRUS THE ROLE OF ACCESSORY PROTEINS AND NITRIC OXIDE IN THE REPLICATION CYCLE

  2008cites this paper
• A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV

  2008cites this paper
• Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses

  2008cites this paper
• B-Cells and Antibodies in Old Humans

  2008cites this paper
• Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals

  2008cites this paper
• Pathogenesis of severe acute respiratory syndrome.

  2008cites this paper
• Intracellular localization of the SARS coronavirus protein 9b: Evidence of active export from the nucleus

  2007cites this paper
• Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

  2007influential citation
• Amino Acid Substitutions in the S2 Region Enhance Severe Acute Respiratory Syndrome Coronavirus Infectivity in Rat Angiotensin-Converting Enzyme 2-Expressing Cells

  2007cites this paper
• The Singapore Contribution in the Battle against the Severe Acute Respiratory Syndrome

  2007cites this paper
• Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

  2007cites this paper
• Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus

  2006cites this paper
• Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein

  2006cites this paper
• Severe Acute Respiratory Syndrome (SARS)

  2006cites this paper
• A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity

  2006cites this paper
• Monoclonal Antibodies Targeting the HR2 Domain and the Region Immediately Upstream of the HR2 of the S Protein Neutralize In Vitro Infection of Severe Acute Respiratory Syndrome Coronavirus

  2006cites this paper
• Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients.

  2006influential citation
• SARS: clinical presentation, transmission, pathogenesis and treatment options.

  2006cites this paper
• Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients

  2006cites this paper
• Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: Implications for the functional roles of S2 subunit

  2006cites this paper
• Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine

  2006cites this paper
• HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins

  2006cites this paper
• Amino acids 15–28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies

  2006cites this paper
• Phage-displayed peptides having antigenic similarities with porcine epidemic diarrhea virus (PEDV) neutralizing epitopes

  2006cites this paper
• Severe acute respiratory syndrome: vaccine on the way.

  2005cites this paper
• Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach

  2005cites this paper
• SARS vaccine development.

  2005cites this paper